#WeightLoss

London — A recent UK study suggests GLP-1 weight-loss injections could halve sickness absence among patients over a nine-month period, a finding that would ease NHS pressure and boost productivity in the wider workforce. Researchers observed that days off work due to illness dropped by about half ... Read full article.

A new daily pill could help individuals maintain weight loss after completing injection treatments, a study suggests. Orforglipron is a GLP-1 agonist taken as a once-daily tablet, designed to lower blood sugar, slow digestion and reduce appetite. The drug, made by Eli Lilly, is significantly ... Read full article.

A new daily pill could help individuals maintain weight loss after completing injection treatments, a study suggests. Orforglipron is a GLP-1 agonist taken as a once-daily tablet, designed to lower blood sugar, slow digestion and reduce appetite. The drug, made by Eli Lilly, is significantly ... Read full article.